FDA Inspection
Rising Pharmaceuticals, Inc.Rising Pharmaceuticals, Inc. – FDA Inspection, Jan 28, 2019
Record Details
This FDA Inspection record concerns Rising Pharmaceuticals, Inc., with an inspection on January 28, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 804bff94-cbff-4943-ad21-b8d4aff91faa
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1077356
- FDA center
- Human Drugs
- Project area
- Postmarket Surv. and Epidemiology
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 314.80(c)(2)Late submission of quarterly safety reports
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Rising Pharmaceuticals, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| January 16, 2019 | NAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
| September 16, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Rising Pharmaceuticals, Inc.
- FDA Inspection 1082645 - 2019-01-16
- FDA Inspection 848700 - 2013-09-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.